Arm & Hammer prepares industry for FDA guidelines

In June 2021, the Food and Drug Administration (FDA) finalized Guidance for Industry (GFI) #263, a guideline that recommends sponsors of “medically important” antimicrobial drugs that are currently approved with over-the-counter (OTC) status to voluntarily transition to Rx status. To better prepare the animal and food production industries for change, Arm & Hammer has released a series of #ScienceHearted resources.

Although Directive #263 is not slated for final implementation until June 11, 2023, many products will begin to disappear from store shelves before that date. Arm & Hammer Animal and Food Production resources are aimed at helping producers find long-term solutions before once-used products are no longer readily available.

“Our commitment to the industries we serve runs deep,” said Ben Towns, global chief commercial officer. “Through our platforms like The Dish and Food Chain Chats, we provide #ScienceHearted resources that aim to improve the lives and operations of those we serve. Now that we’re halfway through the two-year timeline set by the FDA, we’re making sure producers are equipped to handle the changes on the horizon.

On Food Chain Discussions, Arm & Hammer’s Animal and Food Production podcast, industry experts share their insights in lively discussions with host Andy Vance. Producers looking for information on Guidance #263 can log on to Navigating New Over-the-Counter Antibiotic Regulations with guest Dr. Joel Pankowski and Antibiotic-free solutions for health and productivity with guests Dr Sangita Jalukar and Dr Ben Saylor.

On The dishthe Arm & Hammer Animal and Food Production blog, producers will find relevant articles such as Find the right healthcare solutions for your operation by Dr. Sangita Jalukar and Preparing for new over-the-counter antibiotic regulations by Dr. Joel Pankowski.

For more #ScienceHearted resources, visit www.AHfoodchain.com.

Comments are closed.